title: Macrophages and their products in rheumatoid arthritis.
abstract: OBJECTIVE
  Macrophages differentiate from peripheral-blood monocytes. Both monocytes and synovial macrophages are key players in rheumatoid arthritis. These cells are involved in the initiation and perpetuation of inflammation, leukocyte adhesion and migration, matrix degradation and angiogenesis. Macrophages express adhesion molecules, chemokine receptors and other surface antigens. They also secrete a number of chemokines, cytokines, growth factors, proteases and other mediators.
  
  
  RESULTS
  Macrophage migration-inhibitory factor has drawn significant attention recently. This cytokine is involved in macrophage activation and cytokine production. Migration-inhibitory factor also regulates glucocorticoid sensitivity and may be a pathogenic link between rheumatoid arthritis and atherosclerosis. Novel macrophage-derived chemokines and chemokine receptors have been identified. Interleukin-10 may have several proinflammatory effects that may influence its action in rheumatoid arthritis. Several proteinases including cathepsin G are produced by macrophages during rheumatoid arthritis-associated inflammatory and angiogenic events. Antirheumatic drugs, imatinib, chemokine receptor inhibitors and other specific strategies may become included in the therapy of rheumatoid arthritis.
  
  
  CONCLUSIONS
  Macrophages and their products are key players in the pathogenesis of rheumatoid arthritis and may be good therapeutic targets.
authors.affiliation: Division of Rheumatology, Third Department of Medicine, University of Debrecen Medical and Health Sciences Center, Debrecen, Hungary. szekanecz@iiibel.dote.hu
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szekanecz
authors.forename: Alisa E
authors.initials: AE
authors.lastname: Koch
mesh_terms: D000818:Animals; D018501:Antirheumatic Agents / Q000627:therapeutic use; D017209:Apoptosis; D001169:Arthritis, Experimental / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000628:therapy; D001172:Arthritis, Rheumatoid / Q000209:etiology / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D015815:Cell Adhesion Molecules / Q000096:biosynthesis; D002454:Cell Differentiation; D018925:Chemokines / Q000096:biosynthesis; D016207:Cytokines / Q000096:biosynthesis; D006133:Growth Substances / Q000096:biosynthesis; D006801:Humans; D008264:Macrophages / Q000276:immunology* / Q000473:pathology; D051379:Mice; D009389:Neovascularization, Pathologic; D010010:Osteoclasts / Q000276:immunology / Q000473:pathology; D010447:Peptide Hydrolases / Q000378:metabolism; D011480:Protease Inhibitors / Q000378:metabolism; D019707:Receptors, Chemokine / Q000502:physiology
chemical_list: D018501:Antirheumatic Agents; D015815:Cell Adhesion Molecules; D018925:Chemokines; D016207:Cytokines; D006133:Growth Substances; D011480:Protease Inhibitors; D019707:Receptors, Chemokine; D010447:Peptide Hydrolases